Charles Schwab Investment Management Inc. increased its holdings in shares of Keurig Dr Pepper Inc. (NASDAQ:KDP – Free Report) by 3.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,421,067 shares of the company’s stock after buying an additional 176,325 shares during the period. Charles Schwab Investment Management Inc. owned about 0.39% of Keurig Dr Pepper worth $180,630,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors have also recently added to or reduced their stakes in KDP. OFI Invest Asset Management purchased a new position in shares of Keurig Dr Pepper in the third quarter valued at approximately $25,000. Turtle Creek Wealth Advisors LLC acquired a new stake in Keurig Dr Pepper during the 4th quarter worth $29,000. Bruce G. Allen Investments LLC purchased a new stake in shares of Keurig Dr Pepper during the fourth quarter worth $34,000. Ulland Investment Advisors LLC acquired a new stake in shares of Keurig Dr Pepper in the fourth quarter valued at about $50,000. Finally, Operose Advisors LLC lifted its stake in shares of Keurig Dr Pepper by 28.7% in the third quarter. Operose Advisors LLC now owns 1,673 shares of the company’s stock worth $53,000 after buying an additional 373 shares in the last quarter. Institutional investors and hedge funds own 85.23% of the company’s stock.
Keurig Dr Pepper Stock Up 0.9 %
Shares of KDP opened at $33.99 on Friday. The company has a current ratio of 0.51, a quick ratio of 0.34 and a debt-to-equity ratio of 0.52. The firm has a market cap of $46.08 billion, a P/E ratio of 21.93, a price-to-earnings-growth ratio of 2.56 and a beta of 0.61. The company’s 50-day moving average price is $30.92 and its 200 day moving average price is $31.37. Keurig Dr Pepper Inc. has a 12-month low of $27.66 and a 12-month high of $34.65.
Insider Buying and Selling
In other news, insider Roger Frederick Johnson sold 31,227 shares of the firm’s stock in a transaction that occurred on Friday, April 26th. The shares were sold at an average price of $33.82, for a total value of $1,056,097.14. Following the completion of the transaction, the insider now owns 100,000 shares of the company’s stock, valued at $3,382,000. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In related news, CEO Robert James Gamgort purchased 171,821 shares of the business’s stock in a transaction on Tuesday, March 5th. The shares were bought at an average price of $29.10 per share, for a total transaction of $4,999,991.10. Following the acquisition, the chief executive officer now directly owns 3,179,917 shares in the company, valued at $92,535,584.70. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Roger Frederick Johnson sold 31,227 shares of the stock in a transaction dated Friday, April 26th. The shares were sold at an average price of $33.82, for a total value of $1,056,097.14. Following the completion of the sale, the insider now directly owns 100,000 shares in the company, valued at approximately $3,382,000. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 100,085,652 shares of company stock valued at $2,892,832,080. Corporate insiders own 0.81% of the company’s stock.
Analysts Set New Price Targets
Several brokerages recently issued reports on KDP. TD Cowen upped their price objective on shares of Keurig Dr Pepper from $32.00 to $35.00 and gave the company a “hold” rating in a research note on Friday, April 26th. Morgan Stanley cut their price target on Keurig Dr Pepper from $37.00 to $34.00 and set an “equal weight” rating for the company in a report on Monday, February 26th. Barclays boosted their price objective on Keurig Dr Pepper from $36.00 to $38.00 and gave the stock an “overweight” rating in a research note on Monday, April 29th. Jefferies Financial Group cut their target price on Keurig Dr Pepper from $37.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday, March 27th. Finally, Royal Bank of Canada lowered their price target on shares of Keurig Dr Pepper from $42.00 to $41.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. Five research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, Keurig Dr Pepper currently has an average rating of “Moderate Buy” and an average target price of $36.64.
Read Our Latest Report on Keurig Dr Pepper
Keurig Dr Pepper Profile
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
See Also
- Five stocks we like better than Keurig Dr Pepper
- What Are Dividend Contenders? Investing in Dividend Contenders
- JFrog Stock Gets Punished for Solid Results: Buy the Dip
- Using the MarketBeat Dividend Yield Calculator
- Will the Surge in GameStop Stock Spark a New Meme Craze?
- How to Calculate Options Profits
- 3 Stocks Nancy Pelosi Has Been Buying
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.